Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-08-02Clinical Trial Update: A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial of ABT-263 in relapsed or refractory lymphoid malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2021-07-16Clinical Trial Update: Carfilzomib and TGR-1202 in Treatment of R/R Lymphoma [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating carfilzomib and TGR-1202 in relapsed/refractory lymphoma and Hodgkin disease, terminated with results …
-
CLINICAL_TRIALS trial_result · 2021-07-13Clinical Trial Update: Study of ADCT-301 in Patients With Relapsed or Refractory Hodgkin and Non-Hodgkin Lymphoma [Phase 1]
Phase 1 trial update for ADCT-301 in relapsed or refractory Hodgkin lymphoma and non-Hodgkin lymphoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-07-12Clinical Trial Update: A Trial of Pembrolizumab (MK-3475) in Participants With Blood Cancers (MK-3475-013/KEYNOTE-013) [Phase 1]
Phase 1 trial evaluating pembrolizumab (MK-3475) in blood cancers has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-06-14Clinical Trial Update: Intensity Modulated Total Marrow Irradiation (IM-TMI) for Advanced Hematologic Malignancies [NA]
A completed clinical trial evaluating intensity modulated total marrow irradiation (IM-TMI) for advanced hematologic malignancies, with resu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-06-11Clinical Trial Update: Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation [Phase 2]
Phase 2 trial update on Total Body Irradiation with or without Total Lymphoid Irradiation and Anti-Thymocyte Globulin in non-myeloablative h…
-
CLINICAL_TRIALS trial_result · 2021-06-08Clinical Trial Update: Unrelated Umbilical Cord Blood (UBC)Transplantation [NA]
Clinical trial update for unrelated umbilical cord blood transplantation; the study is completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-05-26Clinical Trial Update: Study of OFATUMUMAB as Part of the Scheme of Reduced Intensity Conditioning in High Risk Non-Hodgkin Lymphoma B Patients [Phase 2]
Phase 2 trial evaluating OFATUMUMAB within a reduced intensity conditioning regimen for high-risk B-cell non-Hodgkin lymphoma patients; stud…
-
CLINICAL_TRIALS trial_result · 2021-05-21Clinical Trial Update: Azacytidine, Bendamustine, Piamprizumab in Refractory/Relapsed B-cell Non-Hodgkin's Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial investigating azacytidine, bendamustine, and piamprizumab in refractory/relapsed B-cell non-Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2021-05-18Clinical Trial Update: Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma [Phase 3]
Phase 3 trial evaluating combination chemotherapy with or without rituximab in older adults with non-Hodgkin's lymphoma; completed study.
-
CLINICAL_TRIALS trial_result · 2021-05-18Clinical Trial Update: Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma [Phase 3]
Phase 3 trial evaluating combination chemotherapy followed by radiation therapy for aggressive non-Hodgkin's lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2021-05-18Clinical Trial Update: Outpatient Administration of R-DHAP in Relapsed/Refractory Non-Hodgkin Lymphoma [Phase 1, Phase 2]
A Phase 1/2 trial investigated outpatient administration of R-DHAP in relapsed or refractory non-Hodgkin lymphoma; status completed.
-
CLINICAL_TRIALS trial_result · 2021-05-10Clinical Trial Update: Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma [NA]
Clinical trial update describing a study of bortezomib and filgrastim to promote stem cell mobilization in patients with various B-cell non-…
-
CLINICAL_TRIALS trial_result · 2021-05-07Clinical Trial Update: Study of CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell [Phase 1]
Phase 1 study updating on CAR-20/19-T cells in relapsed/refractory B-cell lymphomas; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2021-05-05Clinical Trial Update: Bortezomib, Rituximab, and Dexamethasone With or Without Temsirolimus in Treating Patients With Untreated or Relapsed Waldenstrom Macroglobulinemia or Relapsed or Refractory Mantle Cell or Follicular Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating bortezomib, rituximab, dexamethasone with or without temsirolimus in untreated or relapsed Waldenström macroglobu…
-
CLINICAL_TRIALS trial_result · 2021-03-11Clinical Trial Update: Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma [Phase 3]
Phase 3 trial update assessing rituximab with combination chemotherapy for non-Hodgkin's lymphoma.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Bendamustine Bridge to Autologous or Allogeneic Transplant for Relapsed/Refractory Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating bendamustine as a bridge to autologous or allogeneic transplant for relapsed/refractory lymphoma has completed wi…
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: A Phase II Trial Using Meloxicam Plus Filgrastim in Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma [Phase 2]
Phase II trial evaluating meloxicam plus filgrastim in patients with multiple myeloma and non-Hodgkin's lymphoma has completed with results …
-
CLINICAL_TRIALS trial_result · 2021-02-15Clinical Trial Update: Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma [Phase 3]
Phase 3 trial evaluating combination chemotherapy with or without rituximab in relapsed non-Hodgkin's lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma [Phase 3]
Phase 3 trial comparing chemoradiotherapy and peripheral stem cell transplantation versus combination chemotherapy in non-Hodgkin's lymphoma…
-
CLINICAL_TRIALS trial_result · 2021-01-28Clinical Trial Update: Study to Evaluate the Safety and Tolerability of Tirabrutinib (ONO/GS-4059) Given as Monotherapy in Participants With Relapsed/Refractory NHL and CLL [Phase 1]
Phase 1 study evaluating tirabrutinib as monotherapy in relapsed/refractory non-Hodgkin lymphoma and chronic lymphocytic leukemia has comple…
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Phase I Dose Escalation Trial of Efavirenz in Solid Tumours or Non-Hodgkin Lymphoma in Therapeutic Failure. [Phase 1]
Phase I dose-escalation study of efavirenz in solid tumors and non-Hodgkin lymphoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Stem Cell Transplant for Hematological Malignancy [NA]
Clinical trial update on stem cell transplantation for hematologic malignancies; status terminated with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial update for antineoplaston therapy in non-Hodgkin lymphoma; study is terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Study of HCD122 in Adults With Non-Hodgkin's or Hodgkin's Lymphoma Who Have Progressed After at Least Two Prior Therapies [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating HCD122 in adults with Non-Hodgkin's or Hodgkin's lymphoma following at least two prior therapies has b…